Comparison of the RMSD values for AlphaFold biomphalysin predictions. by Pierre Poteaux (10507175)

“…When comparing Cα RMSD from ChimeraX matchmaker tool, 89% of the values for small lobe comparison are under 2.0 Å, while only 8% of the values when large lobes are compared (<a href="http://www.plospathogens.org/article/info:doi/10.1371/journal.ppat.1013225#ppat.1013225.s011" target="_blank">S11 Fig</a>). …”

Larger example of stimuli with cue relevant for Task 3. by Marcel F. Hinss (14675457)

<i>r</i>² values for <i>α</i> relationships. by James Cushway (19942288)

The small blue circles show the IC-volume (mean of left and right) from 72 males and the small red squares from 51 females as a function of age. by Pingling Kwok (14896191)

The binding energy values of ATP, ALK inhibitors and ABT-199 to ALK were obtained from AlphaFold and modeled protein structures. by Richard Junior Zapata Dongo (17912565)

Biases in larger populations. by Sander W. Keemink (21253563)

“…<p>(<b>A</b>) Maximum absolute bias vs the number of neurons in the population for the Bayesian decoder. Bias decreases with increasing neurons in the population. …”

Madrasin decreases transcription of protein-coding genes. by Michael Tellier (8284752)

Madrasin decreases transcription of protein-coding genes. by Michael Tellier (8284752)

Introgression decreases allelic shuffling. by Enrique J. Schwarzkopf (6579275)

Participant demographics. * P-values were determined using Fisher-Freeman-Halton test when contingency tables are larger than 2 × 2. by Elie Mulhem (22537863)

Why does task performance decrease with burst length? by Swathi Anil (17382903)

Change in Watt’s Connectedness Scale, Subscales by Treatment Group. by Benjamin R. Lewis (22279166)

Subjects:

Primary and secondary efficacy end points (intention-to-treat population). by Benjamin R. Lewis (22279166)

Subjects:

Demographic and clinical characteristics of participants at baseline. by Benjamin R. Lewis (22279166)

Subjects:

Study-related adverse events. by Benjamin R. Lewis (22279166)

Subjects:

Study flow chart. by Benjamin R. Lewis (22279166)

Subjects:

Change in QIDS-SR-16 and MBI-HSS-MP by Treatment Group. by Benjamin R. Lewis (22279166)

Subjects:

Study CONSORT diagram. by Benjamin R. Lewis (22279166)

Subjects:

Change in Demoralization Scale (DSII) by Treatment Group. by Benjamin R. Lewis (22279166)

Subjects:

Change in Watt’s Connectedness Scale (WCS), General Connectedness by Treatment Group. by Benjamin R. Lewis (22279166)

Subjects: